The Clot Is Not the Whole Story

A wellness chiropractor recently argued that most heart attacks and strokes are caused by clots, not cholesterol, plaque, or calcium.

There is a piece of truth in that statement. Many heart attacks do involve an acute clot. The problem is what gets left out.

In a common heart attack pathway, a clot forms after atherosclerotic plaque ruptures or erodes. The clot can be the event that blocks blood flow, but the plaque is often the disease process that made the event possible.

Leaving that out changes the meaning.

The misleading part is what gets separated

The old “clogged pipe” explanation of heart disease was too simple. Arteries do not merely fill with cholesterol until blood flow stops. Plaque biology is more complicated than that.

But replacing one oversimplification with another does not improve the conversation.

A clot can form quickly. That does not mean the artery was healthy before the clot formed.

In many cases, the clot forms at the site of atherosclerotic plaque rupture or erosion. That process involves lipoproteins, inflammation, endothelial dysfunction, platelet activation, blood pressure, diabetes, smoking, genetics, and metabolic health.

When a video separates the clot from the plaque, it gives patients the wrong frame.

Cholesterol is not the whole story. It is not irrelevant either.

No serious clinician should reduce cardiovascular disease to “cholesterol clogged your arteries.” That explanation is dated and incomplete.

It is also wrong to imply that cholesterol, LDL, apoB, and plaque burden do not matter because a clot is often involved in the final event.

Atherosclerosis develops over years. ApoB-containing particles enter the artery wall. Inflammation follows. Plaque develops. Some plaques remain stable. Others become more vulnerable. When the surface of a plaque ruptures or erodes, the body may form a clot at that site.

That clot can suddenly block blood flow to the heart.

That is why the more accurate explanation is not “heart attacks are clots, not cholesterol.”

A more accurate explanation is that many heart attacks occur when a clot forms on a vulnerable or disrupted atherosclerotic plaque.

Why this matters for patients

When wellness content downplays cholesterol and plaque, patients may stop paying attention to the markers that help us assess real cardiovascular risk.

• apoB
• LDL-P
• LDL-C
• Lp(a)
• blood pressure
• fasting glucose and insulin resistance
• A1c
• hsCRP and inflammatory patterns
• smoking and vaping exposure
• visceral fat and body composition
• sleep apnea
• kidney function
• family history
• coronary calcium, CIMT, or CCTA when appropriate

Those are not abstract numbers. They help identify the conditions that make plaque more likely, arteries more vulnerable, and clots more dangerous.

A video that turns cardiovascular disease into a fight between “clots” and “cholesterol” misses the clinical point.

Clotting matters, but it needs context

Smoking increases vascular injury and clotting risk. Diabetes and insulin resistance increase cardiovascular risk. Inflammation matters. Blood pressure matters. Sleep, exercise, nutrition, body composition, stress, infection burden, alcohol, and environmental exposures can all affect vascular health.

Those are reasonable points.

The problem is using those points to distract from atherosclerosis, apoB, LDL, and plaque burden. Heart disease is not helped by pretending one part of the biology cancels out the rest.

The supplement leap is where patients can get hurt

Wellness content often moves quickly from “clots are involved” to “take natural blood thinners.” That jump deserves scrutiny.

Nattokinase, serrapeptase, bromelain, garlic, omega-3s, and other compounds may affect clotting, inflammation, platelets, or fibrinolytic pathways. That does not mean they are proven to prevent heart attacks.

Mechanism is not outcome data.

Bleeding risk is real. Drug interactions are real. Surgery timing matters. Aspirin, anticoagulants, antiplatelet drugs, NSAIDs, fish oil dosing, liver disease, kidney disease, clotting disorders, atrial fibrillation, prior stroke, and hormone therapy context all matter.

Natural does not mean harmless. It also does not mean clinically appropriate.

What serious prevention looks like

Real cardiovascular prevention does not ignore clotting. It also does not ignore plaque.

At HormoneSynergy®, cardiovascular risk is evaluated through the larger clinical picture. That may include advanced lipid markers such as apoB, LDL-P, and Lp(a), along with blood pressure, glucose, insulin resistance, inflammation, body composition, vascular imaging, hormone context, menopause status, family history, sleep, fitness, nutrition, medication history, and risk-benefit discussion.

For some patients, the most important intervention is smoking cessation. For others, it is blood pressure control, weight loss, resistance training, sleep apnea treatment, glucose improvement, or lowering apoB. Some patients need more advanced imaging. Some need medication. Some need a better lifestyle plan and better follow-through.

The goal is not to worship cholesterol. The goal is to understand the disease process accurately enough to prevent the event.

The HormoneSynergy® take

A clot can cause a heart attack. That does not make cholesterol, apoB, LDL, plaque, and atherosclerosis irrelevant.

The clot is often the final event. Atherosclerosis is often the underlying process that made the event possible.

Patients deserve more than “they lied to you” medicine. They deserve measurement, context, clinical judgment, and prevention that does not flatten cardiovascular disease into a slogan.

Related HormoneSynergy® Resources

• HormoneSynergy® Longevity Medicine Resource Library
• ApoB vs. LDL-C: What Actually Matters?
• LDL-C vs. LDL-P Discordance
• Optimal Aging Assessment vs. Cleerly® Testing

References

• Mayo Clinic: Heart Attack Symptoms and Causes
• European Atherosclerosis Society Consensus Panel: LDL Causes Atherosclerotic Cardiovascular Disease
• American Heart Association: About Heart Attacks

Editorial Transparency

This article is educational and is not personal medical advice. Cardiovascular risk should be evaluated in the context of a full medical history, medications, labs, imaging when appropriate, family history, symptoms, and clinician judgment. Chest pain, shortness of breath, sudden weakness, fainting, or stroke-like symptoms require urgent medical evaluation.